Shandong Wohua Pharmaceutical Co Ltd (002107) - Total Assets
Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) holds total assets worth CN¥955.60 Million CNY (≈ $139.83 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Shandong Wohua Pharmaceutical Co Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Shandong Wohua Pharmaceutical Co Ltd - Total Assets Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. See 002107 live share price for real-time trading data and today's change.
Shandong Wohua Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Shandong Wohua Pharmaceutical Co Ltd's total assets of CN¥955.60 Million consist of 58.0% current assets and 42.0% non-current assets. Explore Shandong Wohua Pharmaceutical Co Ltd short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 40.4% |
| Accounts Receivable | CN¥76.26 Million | 7.8% |
| Inventory | CN¥93.46 Million | 9.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥34.34 Million | 3.5% |
| Goodwill | CN¥32.51 Million | 3.3% |
Asset Composition Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shandong Wohua Pharmaceutical Co Ltd's current assets represent 58.0% of total assets in 2025, a decrease from 59.6% in 2003.
- Cash Position: Cash and equivalents constituted 40.4% of total assets in 2025, up from 24.8% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 14.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 9.6% of total assets.
Shandong Wohua Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Shandong Wohua Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr81.26 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
ASPEN PHAR.UN.ADR /1 O.N.
F:LDZU
|
Germany | €128.04 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Guizhou Bailing Group Pharmaceutical Co Ltd
SHE:002424
|
China | CN¥5.95 Billion |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SHG:600222
|
China | CN¥3.68 Billion |
Shandong Wohua Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.36 | 2.34 | 2.75 |
| Quick Ratio | 1.90 | 1.96 | 2.03 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥322.72 Million | CN¥352.35 Million | CN¥370.14 Million |
Shandong Wohua Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shandong Wohua Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.67 |
| Latest Market Cap to Assets Ratio | 0.64 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | CN¥977.37 Million |
| Market Capitalization | $620.81 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shandong Wohua Pharmaceutical Co Ltd's assets below their book value (0.64x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Shandong Wohua Pharmaceutical Co Ltd's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual total assets of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥977.37 Million ≈ $143.02 Million |
-0.85% |
| 2024-12-31 | CN¥985.73 Million ≈ $144.24 Million |
-13.89% |
| 2023-12-31 | CN¥1.14 Billion ≈ $167.51 Million |
+4.07% |
| 2022-12-31 | CN¥1.10 Billion ≈ $160.96 Million |
-5.26% |
| 2021-12-31 | CN¥1.16 Billion ≈ $169.90 Million |
-15.25% |
| 2020-12-31 | CN¥1.37 Billion ≈ $200.49 Million |
+35.92% |
| 2019-12-31 | CN¥1.01 Billion ≈ $147.51 Million |
+9.29% |
| 2018-12-31 | CN¥922.38 Million ≈ $134.97 Million |
+7.82% |
| 2017-12-31 | CN¥855.50 Million ≈ $125.19 Million |
+21.24% |
| 2016-12-31 | CN¥705.63 Million ≈ $103.26 Million |
+5.60% |
| 2015-12-31 | CN¥668.23 Million ≈ $97.78 Million |
-0.06% |
| 2014-12-31 | CN¥668.64 Million ≈ $97.84 Million |
+3.66% |
| 2013-12-31 | CN¥645.05 Million ≈ $94.39 Million |
+0.21% |
| 2012-12-31 | CN¥643.70 Million ≈ $94.19 Million |
+3.43% |
| 2011-12-31 | CN¥622.35 Million ≈ $91.07 Million |
-2.17% |
| 2010-12-31 | CN¥636.14 Million ≈ $93.09 Million |
-17.80% |
| 2009-12-31 | CN¥773.86 Million ≈ $113.24 Million |
+8.67% |
| 2008-12-31 | CN¥712.11 Million ≈ $104.20 Million |
+57.36% |
| 2007-12-31 | CN¥452.54 Million ≈ $66.22 Million |
+90.93% |
| 2006-12-31 | CN¥237.01 Million ≈ $34.68 Million |
+21.58% |
| 2005-12-31 | CN¥194.94 Million ≈ $28.53 Million |
+27.48% |
| 2004-12-31 | CN¥152.92 Million ≈ $22.38 Million |
+13.30% |
| 2003-12-31 | CN¥134.97 Million ≈ $19.75 Million |
-- |
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more